Cargando…

The development of a public optometry system in Mozambique: a Cost Benefit Analysis

BACKGROUND: The economic burden of uncorrected refractive error (URE) is thought to be high in Mozambique, largely as a consequence of the lack of resources and systems to tackle this largely avoidable problem. The Mozambique Eyecare Project (MEP) has established the first optometry training and hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Stephen, Naidoo, Kovin, Harris, Geoff, Bilotto, Luigi, Ferrão, Jorge, Loughman, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181704/
https://www.ncbi.nlm.nih.gov/pubmed/25246105
http://dx.doi.org/10.1186/1472-6963-14-422
_version_ 1782337405304438784
author Thompson, Stephen
Naidoo, Kovin
Harris, Geoff
Bilotto, Luigi
Ferrão, Jorge
Loughman, James
author_facet Thompson, Stephen
Naidoo, Kovin
Harris, Geoff
Bilotto, Luigi
Ferrão, Jorge
Loughman, James
author_sort Thompson, Stephen
collection PubMed
description BACKGROUND: The economic burden of uncorrected refractive error (URE) is thought to be high in Mozambique, largely as a consequence of the lack of resources and systems to tackle this largely avoidable problem. The Mozambique Eyecare Project (MEP) has established the first optometry training and human resource deployment initiative to address the burden of URE in Lusophone Africa. The nature of the MEP programme provides the opportunity to determine, using Cost Benefit Analysis (CBA), whether investing in the establishment and delivery of a comprehensive system for optometry human resource development and public sector deployment is economically justifiable for Lusophone Africa. METHODS: A CBA methodology was applied across the period 2009–2049. Costs associated with establishing and operating a school of optometry, and a programme to address uncorrected refractive error, were included. Benefits were calculated using a human capital approach to valuing sight. Disability weightings from the Global Burden of Disease study were applied. Costs were subtracted from benefits to provide the net societal benefit, which was discounted to provide the net present value using a 3% discount rate. RESULTS: Using the most recently published disability weightings, the potential exists, through the correction of URE in 24.3 million potentially economically productive persons, to achieve a net present value societal benefit of up to $1.1 billion by 2049, at a Benefit-Cost ratio of 14:1. When CBA assumptions are varied as part of the sensitivity analysis, the results suggest the societal benefit could lie in the range of $649 million to $9.6 billion by 2049. CONCLUSION: This study demonstrates that a programme designed to address the burden of refractive error in Mozambique is economically justifiable in terms of the increased productivity that would result due to its implementation.
format Online
Article
Text
id pubmed-4181704
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41817042014-10-03 The development of a public optometry system in Mozambique: a Cost Benefit Analysis Thompson, Stephen Naidoo, Kovin Harris, Geoff Bilotto, Luigi Ferrão, Jorge Loughman, James BMC Health Serv Res Research Article BACKGROUND: The economic burden of uncorrected refractive error (URE) is thought to be high in Mozambique, largely as a consequence of the lack of resources and systems to tackle this largely avoidable problem. The Mozambique Eyecare Project (MEP) has established the first optometry training and human resource deployment initiative to address the burden of URE in Lusophone Africa. The nature of the MEP programme provides the opportunity to determine, using Cost Benefit Analysis (CBA), whether investing in the establishment and delivery of a comprehensive system for optometry human resource development and public sector deployment is economically justifiable for Lusophone Africa. METHODS: A CBA methodology was applied across the period 2009–2049. Costs associated with establishing and operating a school of optometry, and a programme to address uncorrected refractive error, were included. Benefits were calculated using a human capital approach to valuing sight. Disability weightings from the Global Burden of Disease study were applied. Costs were subtracted from benefits to provide the net societal benefit, which was discounted to provide the net present value using a 3% discount rate. RESULTS: Using the most recently published disability weightings, the potential exists, through the correction of URE in 24.3 million potentially economically productive persons, to achieve a net present value societal benefit of up to $1.1 billion by 2049, at a Benefit-Cost ratio of 14:1. When CBA assumptions are varied as part of the sensitivity analysis, the results suggest the societal benefit could lie in the range of $649 million to $9.6 billion by 2049. CONCLUSION: This study demonstrates that a programme designed to address the burden of refractive error in Mozambique is economically justifiable in terms of the increased productivity that would result due to its implementation. BioMed Central 2014-09-23 /pmc/articles/PMC4181704/ /pubmed/25246105 http://dx.doi.org/10.1186/1472-6963-14-422 Text en © Thompson et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Thompson, Stephen
Naidoo, Kovin
Harris, Geoff
Bilotto, Luigi
Ferrão, Jorge
Loughman, James
The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title_full The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title_fullStr The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title_full_unstemmed The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title_short The development of a public optometry system in Mozambique: a Cost Benefit Analysis
title_sort development of a public optometry system in mozambique: a cost benefit analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181704/
https://www.ncbi.nlm.nih.gov/pubmed/25246105
http://dx.doi.org/10.1186/1472-6963-14-422
work_keys_str_mv AT thompsonstephen thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT naidookovin thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT harrisgeoff thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT bilottoluigi thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT ferraojorge thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT loughmanjames thedevelopmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT thompsonstephen developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT naidookovin developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT harrisgeoff developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT bilottoluigi developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT ferraojorge developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis
AT loughmanjames developmentofapublicoptometrysysteminmozambiqueacostbenefitanalysis